Filter
1208
Filtered Results: 1208
Text search:
rapid
laboratory
confirmation
Featured
Recommendations
177
New Publications
359
Language
Document type
No document type
709
Guidelines
233
Studies & Reports
110
Strategic & Response Plan
60
Manuals
58
Fact sheets
14
Situation Updates
13
Training Material
9
Resource Platforms
1
Infographics
1
Countries / Regions
India
73
Global
37
Kenya
31
South Africa
30
Western and Central Europe
30
Ethiopia
28
Liberia
27
Nigeria
26
Sierra Leone
25
Africa
23
Congo, Democratic Republic of
22
Uganda
20
Latin America and the Carribbean
19
Malawi
18
Tanzania
17
Rwanda
17
Eastern Europe
17
Zambia
16
Nepal
14
Ghana
13
East and Southern Africa
13
West and Central Africa
13
Zimbabwe
11
Philippines
11
Guinea
9
Senegal
9
Syria
9
Bangladesh
9
Colombia
9
Haiti
8
Madagascar
8
Argentina
7
Ukraine
7
Myanmar / Burma
7
Middle East and North Africa
7
Namibia
6
Ecuador
6
South–East Asia Region
6
Asia
6
Cameroon
5
Somalia
5
Pakistan
5
Botswana
5
Western Pacific Region
5
Burkina Faso
4
Mali
4
South Sudan
4
Mozambique
4
Eswatini/ Swaziland
4
Brazil
4
Lesotho
4
Eastern Europe and Central Asia
4
Niger
3
Cambodia
3
Benin
3
Yemen
3
Venezuela
3
Albania
3
Côte d’Ivoire / Ivory Coast
2
Togo
2
Afghanistan
2
Germany
2
Lebanon
2
Turkey
2
Gambia
2
Peru
2
North Macedonia
2
El Salvador
2
Chile
2
Paraguay
2
Russia
2
Georgia
2
France
2
Spain
2
Guinea-Bissau
1
Morocco
1
USA
1
Saudi Arabia
1
Iraq
1
Jordan
1
Chad
1
China
1
Indonesia
1
Sudan
1
Central African Republic
1
Dominican Republic
1
Cuba
1
Burundi
1
Honduras
1
Bolivia
1
Greece
1
Angola
1
Guatemala
1
Mexico
1
Nicaragua
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Estonia
1
Iran
1
Vietnam
1
North America
1
Uruguay
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
468
Clinical Guidelines
177
Public Health
50
Pharmacy & Technologies
42
Key Resources
33
Women & Child Health
24
Capacity Building
15
Toolboxes
TB
163
Rapid Response
133
COVID-19
130
HIV
79
NTDs
72
Ebola
53
Cholera
35
Zika
28
AMR
21
Polio
19
Pharmacy
13
Conflict
11
Natural Hazards
10
Mental Health
10
Caregiver
10
Planetary Health
8
Refugee
7
Specific Hazards
4
NCDs
3
Disability
2
Global Health Education
2
Health Financing Toolbox
1
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
January 2020 to December 2021
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Onchocerciasis used to be an important public health problem in Africa, with over 37 million people infected and millions suffering from debilitating skin disease, terrible itching, impaired vision and
blindness. But the epidemiological situation has improved dramatically over the last two decades....
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only together can they provide essential information to ...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
Colombia is characterized by a fragile and prolonged humanitarian context marked by recurrent multi-hazards affecting its territories and combined with severe structural and systemic challenges within the health system. Recent shocks, including the
COVID-19 pandemic, growing violence within the Col...
